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Summary
 
The outcome of murine infection with 
 
Leishmania major
 
 is regulated by major histocompatibil-
ity complex class II–restricted T helper cells. Invariant chain-deficient (Ii 
 
2
 
/
 
2
 
) mice have im-
paired ability to present major histocompatibility complex class II–restricted antigens, and re-
duced numbers of CD4
 
1
 
 T cells. Despite these deficits, C57BL/6 Ii 
 
2
 
/
 
2
 
 mice controlled 
 
L.
major
 
 infection comparably to wild-type mice. As assessed by mRNA analysis and in vitro anti-
gen restimulation for IFN-
 
g
 
, Ii 
 
2
 
/
 
2
 
 mice had normal induction of Th1 subset differentiation
even though antigen-dependent proliferation of their lymph node cells was substantially com-
promised. In addition, BALB/c Ii 
 
2
 
/
 
2
 
 mice exhibited a progressive course of infection and
Th2 effector cell development that were comparable to that seen in wild-type BALB/c mice.
We wished to determine whether this unexpected efficiency of T helper subset induction de-
spite inefficient T cell stimulation could be modeled in vitro. In the presence of rIL-12 or rIL-4
naive parasite-specific transgenic T cells could mature into IFN-
 
g
 
–or IL-4–secreting T helper
cells, respectively, even when antigen presentation was suboptimal or antigen dose was submi-
togenic. These experiments demonstrate that activation of T helper cells to a threshold re-
quired for IL-2 production or proliferation is not required to achieve induction of disease-reg-
ulating T helper cell effector functions, and that pathogen-associated secondary activation
signals may facilitate the full differentiation of T helper subsets during limiting presentation of
antigenic peptides.
 
E
 
xperimental infection of inbred strains of mice with
 
Leishmania major
 
 remains an exceptional model for
analysis of CD4
 
1
 
 subset differentiation in vivo (1). Control
of disease is dependent on class II–restricted Th type 1 (Th1)
cells and their production of IFN-
 
g 
 
which is required to
activate macrophages to restrain intracellular replication of
the organism. Studies in T cell– (2–4) and IFN-
 
g
 
–deficient
(5) mice have confirmed the critical requirements for these
elements in host immunity. MHC class II–deficient mice
from a genetically resistant background are completely suscep-
tible to infection (6, 7), while MHC class I–deficient mice
from a genetically resistant background retain resistance to
infection (8). In contrast to most strains of mice, BALB
animals are unable to contain 
 
L. major
 
 due to the devel-
opment of an aberrant Th type 2 (Th2) response during
infection. The absence of class I does not impact Th2 de-
velopment or susceptibility in BALB/c mice (9).
 
Leishmania
 
 replicates productively only in host macrophages
within an endolysosomal-like compartment that contains
MHC class II molecules, some of which are devoid of invari-
ant chain (10, 11). Infection of macrophages in vitro is as-
sociated with diminished MHC class II–dependent presen-
tation of exogenous antigens (12, 13). Although it is unclear
whether this is due to degradation or inappropriate traffick-
ing of MHC class II/peptide complexes from the parasito-
phorous vacuole (14), competent MHC class II molecules
reach the cell surface as demonstrated by immunofluorescent,
functional, and biochemical studies (12, 13, 15). Since in-
variant chain is involved in both targeting newly synthesized
MHC class II molecules to peptide-generating compartments,
and in protecting the peptide cleft during transit from the
endoplasmic reticulum (16), we expected significant impair-
ment in host immune responses to 
 
L. major
 
 using invariant
chain–deficient (Ii 
 
2
 
/
 
2
 
) mice. Unexpectedly, both Th1 and
Th2 responses were maintained in mice on genetically resis-
tant or susceptible backgrounds, respectively, emphasizing the
capacity of the immune system to sustain T cell effector de-
velopment even under conditions of suboptimal stimulation.
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Leishmaniasis in Invariant Chain–deficient Mice
 
Materials and Methods
 
Mice.
 
Ii 
 
2
 
/
 
2
 
 mice (17), class II 
 
2
 
/
 
2
 
 mice (18), 
 
b
 
2m 
 
2
 
/
 
2
 
mice (19), BALB/c (Jackson Laboratory, Bar Harbor, ME), and
C57BL/6 (Jackson Laboratory) mice were bred and maintained
in the University of Chicago animal facilities. Double mutant Ii
 
2
 
/
 
2
 
 
 
b
 
2m 
 
2
 
/
 
2
 
 mice were generated by interbreeding. Mice
were screened by fluorescent cytometry using appropriate mono-
clonal antibodies for levels of MHC class I, class II, CD4
 
1
 
 and
CD8
 
1
 
 T cells to confirm genotypes. Most mice used in these ex-
periments were fourth generation C57BL/6, or fourth generation
BALB/c. Mice on a 129 
 
3
 
 C57 (
 
L. major
 
–resistant) background,
but congenic for H-2
 
d
 
 and H-2
 
k
 
, were used where designated.
TCR transgenic mice that express a clonotypic V
 
a
 
8/V
 
b
 
4
TCR expanded early after infection by 
 
L. major
 
 (20), were estab-
lished using standard methods, and are characterized elsewhere
(Reiner, S., manuscript in preparation). T cells from these mice
recognize an 18–amino acid peptide epitope restricted by I-A
 
d
 
from an immunodominant antigen, Leishmanial receptor for acti-
vated protein kinase (LACK)
 
1
 
, that is expressed in both the pro-
mastigote and amastigote forms of the parasite (21). Thymic se-
lection but not peripheral activation, of the transgene clonotype
occurs on the mismatched H-2
 
k
 
 background.
 
L. Major Infection.
 
Mice were inoculated in both hind foot-
pads with 5 
 
3
 
 10
 
5
 
 metacyclic promastigotes of 
 
L. major
 
(WHOM/IR/-/173), maintained and purified as described (22).
Designated mice received 2 mg of mAB XMG1.2 (neutralizing
anti–IFN-
 
g
 
, rat IgG1) intraperitoneally at the time of infection.
Disease progression was monitored weekly by measuring the
footpads with a metric caliper. After 6–8 wks, the popliteal lymph
nodes draining the lesions were collected for the analysis of cell
phenotypes, number, and cytokine production (below). Aliquots
of the single-cell suspensions were analyzed for numbers of CD4
 
1
 
and CD8
 
1
 
 T cells by fluorescent flow cytometry after staining
with the appropriate mAb’s. The footpads were washed in etha-
nol, rinsed in HBSS, and homogenized in 3 ml M-199 medium.
The spleens were homogenized in 3 ml M-199 medium. Aliquots
were serially diluted into flat-bottom 96-well microtiter plates,
and the plates were sealed with parafilm and incubated at 26
 
8
 
C
for 2 wks. Wells were examined for the presence of the motile
promastigotes by inverted microscopy to determine the tissue
parasite burdens.
 
Cytokine and Lymphoproliferation Analyses.
 
Popliteal lymph nodes
draining the site of infection were collected 6–8 wks after infec-
tion. Single-cell suspensions were made and triplicate aliquots
were distributed to 96-well round-bottom plates for determina-
tions of cytokine production (10
 
6
 
 cells/well) and proliferation
(1.5 
 
3
 
 10
 
5
 
 cells/well) in the presence of media or media plus 100
 
m
 
g/ml soluble 
 
Leishmania
 
 antigen (SLA). For cytokine analysis,
supernatants were collected after 48 h incubation and quantitated
for IL-2, -4, or IFN-
 
g
 
 using ELISA (PharMingen, San Diego,
CA). For proliferation analysis, wells were pulsed after 72 h with
1 
 
m
 
Ci [
 
3
 
H]thymidine, and harvested 16 h later.
For cytokine mRNA analysis, total RNA was extracted from
popliteal lymph nodes using RNAzol (Biotecx, Houston, TX),
and reverse transcribed using random hexamer primers (Promega
Corp., Madison, WI). A multiple cytokine–containing competi-
tor construct was used for PCR-based semi-quantitation as de-
scribed (23). Briefly, amounts of cDNA from the different sam-
ples were first normalized by adjusting for competition with the
constitutively expressed hypoxanthine-guanine phosphoribosyl-
transferase (HPRT) gene product. The competitor PCR prod-
ucts were engineered as larger amplification products by insertion
of an internal irrelevant DNA sequence, thus allowing their ready
separation from the authentic transcripts by their differential mo-
bility after electrophoresis in 2.5% agarose gels. These adjusted
cDNA volumes were used in subsequent reactions with primers
for IL-4 or IFN-
 
g
 
 which were also present in the competitor
plasmid. The ratio of the competitor to the authentic cytokine
transcripts was used to quantitate mRNA production in vivo.
 
Antigen Presentation Assays.
 
Bone marrow cells were flushed
from the femurs of H-2
 
d
 
 Ii 
 
1
 
/
 
2
 
 and 
 
2
 
/
 
2
 
 littermates, and ad-
herent cells allowed to differentiate for 5–7 d in media containing
30% L929 cell supernatant. The adherent macrophages were har-
vested after incubation for 30 min in PBS with 2% glucose,
washed, counted, and redistributed to wells containing fresh me-
dia, or media containing SLA, viable metacyclic promastigotes, or
freshly thawed and washed amastigotes isolated from infected mice
and stored in 10% DMSO/FCS at 
 
2
 
70
 
8
 
C (Amastigotes retain in-
fectivity when stored in this fashion.) Infection was monitored in
concomitantly inoculated monolayers established on tissue-cul-
ture chambered slides which were fixed and stained with Dif-
Quik (Dade Diagnostics, Aguada, P.R.). Infection of 5 
 
3
 
 10
 
4
 
macrophages with 2.5 
 
3
 
 10
 
5
 
 parasites typically resulted in 
 
z
 
50%
of the cells infected with 1–3 parasites/macrophage. After 20 h, the
antigen- or parasite-pulsed monolayers were washed extensively,
and designated numbers of T cells from TCR transgenic mice
(H-2
 
k
 
) lymph nodes were added to the wells. Supernatants were
harvested after 48 h and assayed for IL-2 and IFN-
 
g
 
 production
by ELISA. In designated experiments, splenocytes from Ii 
 
1
 
/
 
2
 
or 
 
2
 
/
 
2
 
 littermates were irradiated and used as APCs. There were
no measured alloreactive responses from the use of H-2
 
k
 
–derived
TCR transgenic T cells with H-2
 
d
 
–derived APCs.
 
Results
 
Ii 
 
2
 
/
 
2
 
 Mice on a Resistant Background Control Infection
with L major. 
 
C57BL/6 Ii 
 
2
 
/
 
2
 
 and Ii 
 
1
 
/
 
2
 
 mice were
challenged with 
 
L. major
 
, and the course of infection mon-
itored by measuring the size of the local lesions. Both
groups of mice, in contrast to a concomitantly inoculated
cohort of susceptible BALB/c mice, controlled infection
and limited the size of the footpad lesion (Fig. 1 
 
A
 
). As in
immunocompetent mice (24), control of the parasite was
dependent on the production of IFN-
 
g
 
, because treatment
of mice with anti–IFN-
 
g
 
 neutralizing mAb abrogated the
resistance phenotype. Delayed-type hypersensitivity re-
sponses to injected 
 
Leishmania
 
 antigens were also compara-
ble in Ii 
 
2
 
/
 
2
 
 and 
 
1/2 mice (data not shown). Mice on
two additional MHC backgrounds (H-2d, and H-2k) with
the Ii 2/2 genotype also maintained resistance to L. major
(data not shown).
The Ii 2/2 mice have an expanded population of
CD81 T cells that, in some instances, have been shown to
exert immunologic activity in experimental leishmaniasis
(25, 26). Since b2m 2/2 mice have been demonstrated to
control primary L. major infection comparably to wild-type
mice (8), these mice were bred into the Ii 2/2 back-
1Abbreviations used in this paper: HPRT, hypoxanthine-guanine phospho-
ribosyl transferase; LACK, Leishmanial receptor for activated protein ki-
nase C; SLA, soluble Leishmania antigen.33 Brown et al.
ground, and the experiment was repeated to rule out a
contribution by the CD81 T cell compartment. Again,
Ii 2/2 mice controlled the local lesion as well as Ii 1/2
or 1/1 mice in the presence or absence of b2m (Fig. 1 B).
To confirm that measurements of the local lesions corre-
lated with tissue parasite burdens, dilutions of footpad and
spleen were incubated in vitro and the numbers of recov-
ered parasites were quantitated microscopically (Fig. 2).
Although there was some variability among experiments,
Ii 2/2 mice had comparable or even lower numbers of
recovered organisms than Ii 1/2 mice in both tissues.
Both Ii 2/2 and 1/2 mice, however, had significantly
lower numbers of parasites than genetically susceptible
BALB/c mice. The capacity of the Ii 2/2 mice to control
L. major contrasted sharply with the inability of class II 2/2
mice to resist infection. These latter mice demonstrated
unrestrained progression of the local lesion and large num-
bers of parasites in the footpad and spleen after 8 wk of in-
fection (Fig. 2).
Ii 2/2 Mice on a Resistant Background Generate Type I Im-
mune Responses during Infection. Popliteal lymph node cells
draining the lesions of infected mice were restimulated in
vitro with soluble parasite antigens to assess the qualitative
cytokine response. IFN-g was recovered from supernatants
of stimulated cells from infected Ii 2/2 and b2m 2/2
Ii 2/2 mice at levels comparable to or greater than cells
from Ii 1/2 mice (Fig. 3 A). Production of IFN-g in vitro
was reduced to less-than-detectable levels if anti–class II
monoclonal antibody, but not an isotype control antibody,
was included during the period of antigen stimulation (data
not shown). IL-4, which was readily recovered by stimula-
tion of cells from susceptible BALB/c mice, was not de-
tected. Similar results were obtained analyzing the expres-
sion of IFN-g and IL-4 transcripts in lymph node cells
immediately after removal from infected animals (Fig. 3 B).
Taken together, these data suggest that the deficiency in Ii
expression does not impede the development of a class II–
dependent type 1 immune response to L. major. Th1 effec-
tor development was comparable in Ii 2/2 mice on H-2b,
H-2k, and H-2d backgrounds, despite the differences in ef-
ficient assembly of these different class II molecules in the
absence of Ii (27).
T Cell Proliferation and IL-2 Production Induced by L. major
Is Ii Dependent. The unusual intracellular compartment
occupied by Leishmania amastigotes raised the possibility that
peptides from the organisms might normally access class II
in an Ii-independent manner. However, we found that an-
Figure 1. Ii 2/2 mice on a resistant background control L. major in-
fection. (A) Mice were inoculated in the hind footpads with promasti-
gotes of L. major, and the course of disease followed by measuring the size
of the footpads with time. A cohort of BALB/c mice was inoculated con-
currently to assess virulence of the inoculum. Designated C57BL/6 Ii 2/2
mice were treated with neutralizing anti–IFN-g antibody as noted. Data
points are means and standard deviations of groups of animals, and are
representative of nine separate experiments involving 30 Ii 2/2 mice.
(B) Ii 2/2 mice on a resistant background were crossed to bm 2/2 to
create double mutant animals and infected with promastigotes of L. major
in the hind footpads. Cohorts of b2m 2/2 and Ii 1/2 animals, together
with susceptible BALB/c mice, were inoculated at the same time. Data
points are means and standard deviations and representative of results ob-
tained with 6 Ii 2/2 b2m 2/2 mice.
Figure 2. Resistance in Ii 2/2
mice represents control of parasite
growth in tissues. Cohorts of
C57BL/6 Ii 2/2 or Ii 1/2 mice,
together  with class II 2/2 and
susceptible BALB/c mice, were
infected with L. major and, after 8
wk, the popliteal lymph nodes and
spleens were homogenized in
equivalent volumes of media and
serially diluted into growth media
that supported the conversion of
intracellular organisms to the
extracellular promastigotes. Wells
were examined 2 wk later for
motile promastigotes using in-
verted microscopy.34 Leishmaniasis in Invariant Chain–deficient Mice
tigen-induced proliferation of lymph node cells taken from
infected animals was significantly impaired in Ii 2/2, as com-
pared to I 1/2, mice, demonstrating substantial Ii-depen-
dence for optimal antigen presentation (Fig. 4). Assays us-
ing the same groups of cells showed comparable levels of
antigen-induced IFN-g, revealing dissociation of these two
lymphocyte activities under the conditions used (Fig. 4).
To further characterize the deficiency in presentation of
parasite-derived antigens by Ii 2/2 cells, bone marrow–
derived APCs were established from H-2d Ii 2/2 and 1/2
mice and used to measure activation of I-Ad–restricted
TCR transgenic T cells that recognize an epitope from an
immunodominant antigen of L. major designated LACK
(21). After preincubating APCs for 20 h with the 18–
amino acid peptide epitope, production of IL-2 in the su-
pernatant (Fig. 5) was consistently enhanced using Ii 2/2,
as compared to Ii 1/2, cells, in agreement with prior ex-
periments (17, 28, 29). Processing and presentation of the
LACK epitope from SLA, viable promastigotes, or intracel-
lular amastigotes, however, revealed that only Ii 1/2 APCs
Figure 3. Ii 2/2 mice de-
velop type 1 immune responses
during infection with L. major.
(A) Lymph node cells from the
designated mice were collected 8
wk after infection with L. major,
and incubated as described in the
Materials and Methods, with or
without soluble Leishmania anti-
gens for 48 h. Supernatants were
assayed for IFN-g and IL-4 by
ELISA. Points indicate quantities
present in antigen-stimulated
wells. All incubations in the ab-
sence of antigen resulted in cy-
tokine recoveries ,7 U/ml, ex-
cept for one b2m 2/2 animal with an IFN-g level of 19 U/ml, and the
BALB/c with an IL-4 level of 100 U/ml. Data points represent means
and standard deviations of triplicate determinations, and are representa-
tive of five separate experiments. (B) Total RNA from lymph node cells
from infected Ii 1/1 (1/1), 2/2 (2/2), or BALB/c (B/c) mice was
reverse transcribed and subjected to PCR amplification in the presence of
a competitor construct containing mutated cDNAs (upper bands) z75 bp
larger than the authentic transcripts (lower bands). After standardizing the
input cDNA for the amounts of the constitutively expressed HPRT gene
product, the amounts of IFN-g and IL-4 were determined using the req-
uisite primers. These results are representative of three separate experi-
ments.
Figure 4. IFN-g production is maintained in infected Ii 2/2 mice,
despite suboptimal proliferation. Lymph node cells were prepared from
Ii 1/2 or 2/2 mice infected 8 wk before with L. major, and incubated
with or without soluble Leishmania antigens as described in the Materials
and Methods. After 48 h, supernatants were collected and assayed for the
presence of IFN-g by ELISA (right). After 72 h, wells were pulsed with
1 mCi[3H]thymidine, and the cells harvested 16 h later to measure incor-
poration of radioactivity. Data points on the left represent results in the
absence of antigen, and on the right, in the presence of antigen. Data rep-
resent three individual mice from each group, and are representative of
three separate experiments. Values are means and standard deviations of
triplicate determinations.
Figure 5. Optimal stimulation of LACK-reactive transgenic T cells is Ii
dependent. Bone marrow–derived macrophages were established from
Ii 1/2 or 2/2 littermates and incubated with varying amounts of the
18–amino acid peptide epitope of LACK (Peptide), soluble Leishmania an-
tigens (SLA), live promastigotes (Promast.), or live amastigotes (Amast.) for
20 h as described in the Materials and Methods. The monolayers were
washed and 105 TCR transgenic T cells added to 5 3 104 macrophages.
After 48 h, the supernatants were assayed for the presence of IL-2 by
ELISA. Data points represent means and standard deviations of triplicate
determinations, and are representative of four separate experiments.35 Brown et al.
could induce the transgenic T cells to release significant
levels of IL-2. Thus, optimal activation of these transgenic
T cells by processed antigen is Ii dependent.
IFN-g Production Can Be Induced by IL-12 at Suboptimal
Antigen Thresholds. The striking preservation of the IFN-g
response in vivo and in vitro suggested that costimulatory
signals triggered by the organisms might compensate for
the Ii 2/2 defect in antigen presentation. IL-12, induced
by the intracellular forms of L. major (22), is required for
optimal IFN-g production and control of infection (30–32),
and is required for Th1 effector cell development (33, 34).
Stimulation of transgenic T cells (Fig. 6) with LACK pep-
tide at levels .0.1 mM presented by normal Ii 1 APCs, al-
lowed the ready recovery of IL-2, but not IFN-g, from
culture supernatants. Below this concentration of peptide,
neither IL-2 nor proliferation was induced. Using subopti-
mal concentrations of the peptide, however, the addition
of recombinant IL-12 (rIL-12) induced the dose-depen-
dent production of IFN-g by transgenic T cells not accom-
panied by IL-2 recovery in the supernatants (Fig. 6).
To confirm that rIL-12 could sustain IFN-g production
under conditions where the numbers of class II/peptide
complexes might be limited, experiments were carried out
using the same preparations of normal Ii 1 APCs in which
either amounts of peptide, numbers of APCs, or numbers
of accessible class II/peptide complexes were titrated. For
the latter condition, dilutions of anti–class II monoclonal
antibody were included in the cultures during the period of
presentation to transgenic T cells. All of the experiments
were performed in the presence of rIL-12. Supernatants
were collected after 48 h and analyzed for the presence of
IL-2 and IFN-g (Fig. 7). Under each set of conditions, the
amount of IL-2 recovered was directly related to the de-
gree of class II–dependent stimulation. In contrast, under
these same conditions, the amount of IFN-g recovered was
essentially stable. Thus, as assessed using these transgenic T
Figure 6. IL-12 induces IFN-g
production from TCR trans-
genic T cells at suboptimal levels
of stimulation. Splenocytes from
Ii1 mice were incubated in ei-
ther the absence (0) or presence
of increasing amounts of the
LACK peptide epitope, in the
absence (open symbols) or pres-
ence of increasing amounts of
rIL-12 (filled symbols), as desig-
nated on the lower axis. Each
well contained 2 3 105 Ii 1
APCs and 2 3 105 TCR trans-
genic lymph node T cells. After
48 h, supernatants were collected
and assayed for IL-2 and IFN-g
by ELISA. Data points represent
means and standard deviations
from duplicate determinations,
and are representative of three
separate experiments.
Figure 7. IL-12 sustains T
cell IFN-g production at sub-
optimal levels of stimulation.
Splenocytes from Ii1 mice were
incubated with varying amounts
of the LACK peptide epitope
(Peptide; 5 3 105 APCs/well),
inoculated into wells at varying
numbers (APCs; 2.5 mM pep-
tide), or inoculated into wells us-
ing a fixed number of cells and
amount of peptide (a–class II;
5 3 105 APCs/well, 1.25 mM
peptide). After washing, 2 3 105
TCR transgenic lymph node T
cells were added to the wells in
the presence of rIL-12 (2 ng/ml).
In the right panel, anti-class II mAb M5/114 was titrated into the wells using the dilutions shown. Supernatants were collected after 48 h and assayed for
IL-2 and IFN-g using ELISA. Values represent means and standard deviations of triplicate determinations, and are representative of three separate exper-
iments.36 Leishmaniasis in Invariant Chain–deficient Mice
cells, and as suggested by cells recovered from infected
mice (Fig. 4), IL-12 preserves IFN-g production under
conditions suboptimal for inducing IL-2 or lymphoprolif-
eration.
IL-12 Can Preserve IFN-g Production by T Cells Primed on
Ii 2/2 APCs. To confirm that rIL-12 could similarly
sustain IFN-g production from T cells primed on Ii 2/2
APCs, Ii 1/2 or 2/2 APCs were incubated with varying
concentrations of the recombinant LACK antigen and trans-
genic T cells in the presence of rIL-12. After 48 h, superna-
tants were analyzed for IL-2 and IFN-g (Fig. 8 A). Consis-
tent with the earlier results using normal APCs under
conditions of low antigenic stimulation, T cells primed on
Ii 2/2 APCs generated IFN-g that was comparable to
that generated by T cells primed on Ii 1/2 APCs, al-
though only the latter generated IL-2 that could be recov-
ered in supernatants. Recovery of IFN-g was dependent
on both antigen and rIL-12; in the absence of either, no
cytokine could be recovered from transgenic T cells primed
on Ii 2/2 APCs. This experiment additionally confirms
that the LACK protein antigen, in contrast to the immuno-
genic LACK peptide (Fig. 5), requires Ii for optimal pre-
sentation.
The development of Th1 effector cells is mediated by
IL-12–dependent priming during the initial encounter of
naive T cells with the appropriate peptide/MHC com-
plex (33). To confirm that the IL-12-induced responses
by T cells primed on Ii 2/2 APCs extended to second-
ary responses, transgenic T cells were primed using anti-
gen-pulsed Ii 1/2 or 2/2 APCs in the presence or ab-
sence of rIL-12. After 6 d, viable cells were purified and
redistributed to wells containing fresh antigen-pulsed Ii
1/2 or 2/2 APCs in the absence of IL-12. After 48 h,
supernatants were collected and analyzed for IFN-g (Fig.
8 B). As assessed under these conditions, transgenic T cells
stimulated with Ii 2/2 APCs displayed even greater pro-
duction of IFN-g than T cells stimulated with Ii 1/2
APCs, and the production of IFN-g was dependent on
the presence of rIL-12 during the primary stimulation
with LACK.
Ii 2/2 Mice on a Susceptible Background Generate Type 2
Immune Responses during Infection. The finding that Th1
development was maintained in Ii 2/2 mice on a resistant
background might be partially explained by effects of low
antigen dose on Th subset development. Antigen dosage
effects on subset differentiation have been demonstrated us-
ing TCR transgenic T cells in vitro (35, 36), and have been
supported by observations in L. major infection. Thus, sus-
ceptible BALB/c mice have been rendered resistant by ei-
ther administration of low numbers of parasites (37), or
through interventions such as anti-CD4 monoclonal anti-
body (38) or sublethal irradiation (39) that decrease the
numbers of responding T cells. The impaired antigen pre-
sentation and diminished CD41 T cell numbers in Ii 2/2
mice might independently bias Th subset differentiation to
the Th1 phenotype.
To test this prediction, Ii 2/2 mice were bred four
generations onto the susceptible BALB/c background, and
Ii 2/2 and 1/2 littermates were infected with L. major.
As assessed by monitoring of the local footpad lesions,
BALB/c Ii 2/2 suffered disease that was comparable to
Ii 1/2 littermates, and both differed markedly from the
course of infection in concurrently infected C57BL/6 Ii 2/2
or Ii 1/1 mice (Fig. 9 A). Quantitation of parasites recov-
Figure 8. IL-12 can maintain IFN-g production and implement Th1 development by T cells primed on Ii 2/2 APCs. (A) Irradiated spleen cells (105/
well) from Ii 12 (filled symbols) or Ii 2/2 (open symbols) H-2d littermates were incubated with varying amounts of recombinant LACK Ag in the pres-
ence of 2 3 105 TCR transgenic lymph node cells and 2 ng/ml of rIL-12. After 48 h, supernatants were assayed for IL-2 and IFN-g using ELISA. Values
represent means and standard deviations from triplicate determinations, and are representative of four separate experiments. (B) B2201 cell–depleted
TCR transgenic lymph node cells (2 3 105 cells/well) were stimulated in a 1 ml volume in 24-well plates with either Ii 1 or Ii 2/2 irradiated H-2d
spleen cells (1 3 106 cells/well), plus recombinant LACK antigen (2 mg/ml), with (1) or without (2) rIL-12 (0.5 ng/ml) as designated on the x-axis.
6 d later, viable cells were purified and washed, and 2 3 105 T cells were restimulated with the same Ii-genotype APCs (1.2 3 106/well) used in the pri-
mary stimulation in the presence of antigen (2 mg/ml), but without rIL-12. After 48 h, supernatants were collected and assayed for IL-2 and IFN-g by
ELISA. Values represent means and standard deviations of triplicate determinations, and are representative of two separate experiments.37 Brown et al.
ered from the footpads and spleen corroborated the lesion
measurements (data not shown). Lymph node cells recov-
ered from infected animals and incubated with SLA in vitro
generated readily recovered IL-4 that was not obtained us-
ing lymph node cells from C57BL/6 mice (Fig. 9 B). Thus,
Th2 cell differentiation in vivo was also maintained in the
absence of invariant chain.
To confirm that the threshold for Th2 development
could be maintained in the absence of invariant chain,
LACK-specific transgenic T cells were primed using anti-
gen-pulsed, irradiated spleen cells from Ii 1 or Ii 2/2
mice in the presence or absence of rIL-4. After 6 d, viable
cells were washed extensively, counted, and redistributed
with freshly prepared, antigen-pulsed, irradiated spleen
cells from the same Ii backgrounds, but in the absence of
rIL-4. After 48 h, the supernatants were analyzed for IL-4
(Fig. 10). Recovery of IL-4 was substantially enhanced
during the secondary stimulation when cells were primed
using Ii 2/2 APCs, but only when rIL-4 was included
during the primary incubation with LACK.
Discussion
Infection with L. major is a well-characterized model in
which differentiation of class II–restricted T cells into the
two mature helper subsets is required for expression of the
resistant and susceptible disease phenotype. Ii is required
for stable expression of surface class II molecules and, as
predicted, cells from Ii 2/2 mice have substantially lower
amounts of surface class II that do not assume the compact
conformation that characterizes stable peptide binding (17,
28, 29). The major immunologic consequences are two-
fold: a severely compromised ability to present processed
antigens via the class II pathway, and a quantitatively and
qualitatively altered CD41 population due to aberrant se-
Figure 9. BALB/c Ii 2/2
mice are susceptible to L. major
infection and generate type 2
immune responses. (A) Groups
of fourth generation BALB/c Ii
1/2 or Ii 2/2 and C57BL/6
(B6) Ii 1 or Ii 1/2 mice were
infected in the hind footpads
with promastigotes of L. major,
and the size of the footpad le-
sions measured using a metric
caliper. Data represent means
and standard deviations of foot-
pad lesions in four separate ex-
periments involving 12 BALB/c
Ii 2/2 mice. (B) Lymph node
cells were prepared from individ-
ual mice after 7 wk of infection
and were cultured with and with-
out soluble Leishmania antigens as
described in the Materials and
Methods. After 48 h, the super-
natants were assayed for IL-4 by
ELISA. Cells cultured without
antigen yielded ,20 U/ml IL-4.
C57BL/6 (B6) mice are compared
to BALB/c Ii 1/2 and 2/2
mice. Values represent means and
standard deviations of triplicate
determinations for individual an-
imals, and are representative of
three separate experiments.
Figure 10. IL-4 supports Th2 differentiation by T cells primed on Ii 2/2
APCs. CD4-selected TCR transgenic lymph node cells (2 3 105 cells/
well) were stimulated in a 1 ml volume in 24-well plates with either Ii 1 or
Ii 2/2 irradiated H-2d spleen cells (1 3 106 cells/well), plus recombinant
LACK antigen (0.5 mg/ml), with (1) or without (2) rIL-4 (5,000 U/ml)
as designated on the x-axis. 6 d later, viable cells were purified and
washed, and 2 3 105 T cells were restimulated with the same Ii-genotype
APCs (1.2 3 106/well) used in the primary stimulation in the presence of
antigen (0.5 mg/ml), but without rIL-4. After 48 h, supernatants were
collected and assayed for IL-4 by ELISA. Values represent means and
standard deviations of triplicate determinations.38 Leishmaniasis in Invariant Chain–deficient Mice
lection by thymic epithelial cells unable to present self pep-
tides in a normal manner (40, 41). Despite this drastic effect
on the class II–dependent immune response, we could dis-
cern little consequence to the host in generating either Th1
or Th2 responses to L. major. How might we explain this
unpredicted outcome?
One possibility is that effector T cells producing IFN-g
or IL-4 are responding to Ii-independent antigens, whereas
proliferating (or nonproliferating, in the case of Ii 2/2
mice) T cells are responding to Ii-dependent antigens. Al-
though it is not possible to dismiss this hypothesis com-
pletely, we think it unlikely for several reasons. First, we
could demonstrate that an immunodominant L. major anti-
gen, LACK, was presented optimally only by cells that
contained Ii and, in studies of infected mice, expansion of
LACK-reactive cytokine-producing T cells can be directly
documented (20). Secondly, our in vitro studies demon-
strated the possibility of achieving effector differentiation in
the absence of discernible IL-2 production or proliferation.
Dissociation of effector function from proliferation has been
recently described among CTL clones that can be triggered
to kill targets at doses of peptide which are several orders of
magnitude below doses required for proliferation (42). Lastly,
a recent study of antiviral immunity demonstrated that the
same antigen which required Ii to elicit IL-2 production from
a hybridoma could elicit specific T helper-dependent anti-
body from infected or immunized Ii 2/2 mice (43). We,
therefore, consider it unlikely that distinct epitopes under-
lie proliferative and cytokine-effector responses.
The unique location of L. major within the class II path-
way may also influence the ability of Ii 2/2 mice to gen-
erate strong anti-parasite immunity. Infection of macrophages
does not limit surface expression of class II, and peptides
eluted from surface class II exhibited comparable diversity
to those from uninfected cells as well as parasite-specific
complexes (15). Comparable experiments have not been
done using infected Ii 2/2 macrophages, but analysis of
the fine specificity of peptides presented by such cells has
indicated that a varied range of epitopes might be presented
by Ii 2/2, as compared to Ii 1/1 APCs (44). The route
by which class II complexes exit the ER or cis-Golgi to
transit to the surface in Ii 2/2 cells is not defined (17, 28,
29). Parasite-derived peptides could stabilize class II in the
endoplasmic reticulum, as described for some endogenous
class II–dependent antigen presentation pathways (45), or
could load class II via a compartment that recycles from the
cell membrane, as described for influenza hemagglutinin
(46). The ability of the parasite to load class II with peptides
or the potential recruitment of additional epitopes may
contribute to an effective immune response in the absence
of Ii. Our direct examination of an epitope known to be
presented in vivo, however, demonstrated that parasite-
specific class II complexes are functionally reduced in Ii 2/2
infected APCs (Fig. 5).
The effects of Ii deficiency on the T cell compartment
must also be considered in understanding the remarkable
preservation of subset effector differentiation. Peripheral
CD41 T cells are reduced to z25% of normal numbers in
Ii 2/2 mice. CD4 2/2 mice have even lower numbers
of class II–restricted T cells in the periphery, yet readily
control L. major infection (6). Acutely decreasing the num-
ber of CD41 T cells can confer protection on otherwise
susceptible BALB/c mice (38). Thus, it may not be surpris-
ing that Ii 2/2 mice have sufficient numbers of T cells to
mount an adequate Th1 response. The reduction in the
T cell compartment of Ii 2/2 mice is probably not an es-
sential compensatory mechanism that allows for Th1 differ-
entiation in C57BL/6 Ii 2/2 mice, however, since BALB/c
Ii 2/2 mice readily develop Th2 responses despite simi-
larly reduced numbers of CD41 T cells. In addition to de-
creased numbers, CD41 T cells from Ii 2/2 mice display an
altered phenotype resembling prior activation (CD45RBlo,
CD44hi, and L-selectinlo, with slightly diminished TCR
expression [17] that is probably due to “incomplete” posi-
tive selection by abnormal class II/peptide complexes on
thymic epithelial cells (41). The “activated” phenotype of
CD41 T cells in Ii 2/2 mice could contribute to a lower
threshold of activation. Resting T cells activated in the
presence of costimulatory ligands responded to lower anti-
gen doses in a manner comparable to activated T cells
(47). Even in the absence of Ii-deficient thymic education,
however, transgenic T cells could be induced to secrete
IFN-g or IL-4 under conditions of limited peptide dose
that was incapable of supporting proliferation or IL-2 pro-
duction.
The finding that IFN-g production by Th1 cells (and
IL-4 production by Th2 cells) was comparable or greater
from Ii 2/2 T cells, despite even fewer class II–restricted
T cells in the lymph nodes, demonstrates striking preserva-
tion of T cell effector function in the setting of suboptimal
antigen presentation. Titrating down the number of class
II/peptide complexes on normal APCs in vitro to levels at
which lymphoproliferation could not be sustained was ac-
companied by no diminution in IFN-g production; similar
findings could be demonstrated using Ii 2/2 APCs as
compared to Ii 1/2 APCs, again consistent with retention
of effector function at levels of class II/peptide that could
not support IL-2 production. Just as the levels of cytokines
produced in Ii 2/2 mice would sometimes exceed those
seen in wild-type mice, activation of transgenic T cells in
vitro often yielded slightly higher IFN-g or IL-4 produc-
tion when antigen was presented by Ii 2/2 APCs. These
results suggest that weaker antigenic stimulation may favor,
rather than limit, effector cytokine production at some
ranges of antigen dose. The mechanism for this finding is
unclear, but may also underly prior observations on the in-
fluence of peptide dose in T helper lineage commitment
(35, 36).
For Th1 development, the preservation or augmentation
of effector function was revealed only in the presence of
rIL-12 and in a dose-dependent manner. The ability of
IL-12 to augment IFN-g production in response to antigen
is well known, and was confirmed in IL-12 p40 2/2
mice, in which IFN-g production was severely impaired39 Brown et al.
but IL-2 production and lymphoproliferation were unaf-
fected (34). The studies reported here suggest that IL-12, at
least for Th1 development, may be one of the signals im-
plicated in “tuning” the threshold for activation by differ-
ing levels of TCR engagement (47). This activity is distinct
from the costimulatory effect of IL-12 on committed Th1
cells, which includes a role in both proliferation and IFN-g
production (48). The ability of IL-4 to support robust Th2
development of parasite-specific T cells primed on Ii 2/2
cells in vitro suggests a similar role for IL-4 in affecting the
threshold for Th2 effector cell function. The efficient de-
velopment of Th1 and Th2 responses in Ii 2/2 mice, at
least in this system, implies that the cellular sources for
IL-12 and IL-4 in infected mice remain unperturbed by the
loss of Ii.
It is intriguing to speculate that signals produced by cells
of the innate immune system, such as IL-12, might be in-
volved in lowering thresholds for distinct types of T cell ef-
fector responses to levels below those required for clonal
expansion. This might enable maximal numbers of poten-
tially protective naive T cells to be recruited at very low
levels of peptide/MHC complex formation, thus limiting
the spread of infection and allowing the sampling of multi-
ple peptide/MHC complexes before clonal expansion and
competition for growth factors and lymph node niches can
occur. The production of inflammatory mediators by mi-
crobial pathogens has a major impact on T cell survival
(49), so perhaps it should not be surprising that they greatly
influence T cell effector functions at low thresholds for ac-
tivation. In this manner, the immune system can focus atten-
tion on the few peptides presented in an inflammatory con-
text, rather than the many peptides presented innocuously.
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